Immunoreactive pancreatic Reg protein in sera from cystic fibrosis patients with and without pancreatic insufficiency

Gut

Volumn 44, Issue 4, 1999, Pages 545-551

  Carrere J ^b   Guy Crotte, O ^a   Gaia, E ^c   Figarella, C ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Hopital Renee Sabran   (France)

^c SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

Cystic fibrosis; Pancreatic insufficiency; Reg protein; Serum

Indexed keywords

CELL PROTEIN; REG PROTEIN; UNCLASSIFIED DRUG;

ACINAR CELL; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PANCREAS INSUFFICIENCY; PANCREAS JUICE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0032956598     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.4.545     Document Type: Article

References (43)

1. Shwachman H, Dooley RR, Guilmette F, et al. Cystic fibrosis of the pancreas with varying degrees of pancreatic insufficiency. Am J Dis Child 1956;92:347-68.
2. Waters DL, Dorney S, Gaskin KJ, et al. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening programme. N Engl J Med 1990;322:303-8.
3. Durie PR, Forstner GG, Gaskin KJ, et al. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res 1986;20:209-13.
4. Guy-Crotte O, Amouric M, Figarella C. Characterization and N-terminal sequence of a degradation product of 14 000 molecular weight isolated from human pancreatic juice. Biochem Biophys Res Commun 1984;125:516-23.
5. Gross J, Carlson RI, Brauer AW, et al. Isolation, characterization, and distribution of an unusual pancreatic human secretory protein. J Clin Invest 1985;76:2115-26.
6. Guy O, Robles-Diaz G, Adrich Z, et al. Protein content of precipitates present in pancreatic juice of alcoholic subjects and patients with chronic calcifying pancreatitis. Gastroenterology 1983;84:102-7.
7. De Caro AM, Bonicel JJ, Rouimi P, et al. Complete amino acid sequence of an immunoreactive form of human pancreatic stone protein isolated from pancreatic juice. Eur J Biochem 1987;168:201-7.
8. Terazono K, Yamamoto H, Takasawa S, et al. A novel gene activated in regenerating islets. J Biol Chem 1988;263:2111-14.
9. Watanabe T, Yonemura H, Terazono K, et al. Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem 1990;265:7432-9.
10. Forstner GG, Vesely SM, Durie PR. Selective precipitation of 14 kDa stone/thread proteins by concentration of pancreaticobiliary secretions: relevance to pancreatic ductal obstruction, pancreatic failure, and CF. J Pediatr Gastroenterol Nutr 1989;3:313-20.
11. Amouric M, Barthe C, Kopeyan C, et al. Protein X, a proteolysis product of human pancreatic juice. Immunological relationship with trypsinogen 1. Biol Chem Hoppe-Seyler 1987;368:1525-32.
12. Christa L, Felin M, Morali O, et al. The human HIP gene, overexpressed in primary liver cancer encodes for a C-type carbohydrate binding protein with lactose binding activity. FEBS Lett 1994;337:114-18.
13. Moriscot C, Renaud W, Carrère J, et al. Developmental gene expression of trypsinogen and lipase in human fetal pancreas. J Pediatr Gastroenterol Nutr 1997;24:63-7.
14. Carrère J, Guy-Crotte O, Figarella C. Human pancreatic reg protein: immunoenzymatic assay and molecular form in serum. Clin Chim Acta 1998;273:185-94.
15. Iovanna JL, Ferec C, Sarles J, et al. The pancreatitis-associated protein (PAP). A new candidate for neonatal screening of cystic fibrosis. C R Acad Sci Paris 1994;317:561-4.
16. Carrère J, Grataroli R, Marfin J, et al. Non-competitive enzyme immunoassay of human trypsin 1. J Immunol Methods 1983;60:235-42.
17. Carrère J, Galabert C, Thouvenot JP, et al. Assay of human pancreatic lipase in biological fluids using a non-competitive enzyme immunoassay. Clin Chim Acta 1986;161:209-19.
18. Carrère J, Figarella C, Guy-Crotte O, et al. Human pancreatic chymotrypsinogen A: a non competitive immunoassay, and molecular forms in serum and amniotic fluids. Biochim Biophys Acta 1986;883:46-53.
19. Chirgwin JM, Przybyla AE, MacDonald RJ, et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
20. Renaud W, Merten M, Figarella C. Increased coexpression of CFTR and S100 calcium binding proteins MRP8 and MRP14 mRNAs in cystic fibrosis human tracheal gland cells. Biochem Biophys Res Commun 1994;201:1518-25.
21. Figarella C, Amouric M, Carrère J, et al. Pancreatic proteins in normal state and pancreatic diseases in pancreatic juice and blood. La Ricerca in Clinica e in Laboratorio 1984;14:349-59.
22. Giorgi D, Bernard JP, Rouquier S, et al. Secretory pancreatic stone protein messenger RNA, nucleotide sequence and expression in chronic calcifying pancreatitis. J Clin Invest 1989;84:100-6.
23. Figarella C, Amouric M, Guy-Crotte O. Proteolysis of human trypsinogen. I. Pathogenic implication in chronic pancreatitis. Biochem Biophys Res Commun 1984;118;154-61.
24. Figarella C, Amouric M, Guy-Crotte O. Enzyme activation and liberation: intracellular/extracellular events. In: Beger HG, Büchler M, eds. Acute pancreatitis. Berlin, Heidelberg: Springer Verlag 1987:53-60.
25. Figarella C, Basso D, Guy-Crotte O. Lysosomal enzyme activation of digestive enzymes during chronic pancreatitis? In: Beger HG, Büchler M, Ditschuneit H, et al, eds. Chronic pancreatitis. Berlin, Heidelberg: Spinger Verlag, 1990:134-9.
26. Satomura Y, Sawabu N, Ohta H, et al. The immunohistochemical evaluation of PSP/reg-protein in normal and diseased human pancreatic tissues. Int J Pancreatol 1993;13:59-67.
27. Bimmler D, Graf R, Scheele GA, et al. Pancreatic stone protein (Lithostathine), a physiologically relevant pancreatic calcium carbonate crystal inhibitor? J Biol Chem 1996;272:3073-82.
28. De Reggi M, Gharib B, Patard L, et al. Lithostatine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals. J Biol Chem 1998;273:4967-71.
29. Figarella C, Carrère J. The evolution of pancreatic disease in cystic fibrosis. In: Dodge JA, Brock DJH, Widdicombe JH, eds. Cystic fibrosis current topics. Chichester, New York, Brisbane, Toronto, Singapore: John Wiley & Sons, 1994;2:255-75.
30. Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979;i:472-4.
31. Schmiegel W, Burchert M, Kalthoff H, et al. Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders. Gastroenterology 1990;99:1421-30.
32. Hayakawa T, Kondo T, Shibata T, et al. Serum pancreatic stone protein in pancreatic diseases. Int J Pancreatol 1993;13:97-103.
33. Carrère C, Serre G, Vincent C, et al. Human serum pancreatic lipase and trypsin 1 in aging: enzymatic and immunoenzymatic assays. J Gerontol 1987;42:315-17.
34. Senegas-Balas F, Figarella C, Amouric M, et al. Immunohistochemical demonstration of a pancreatic secretory protein of unknown function in the human duodenum. J Histochem Cytochem 1991;39:915-19.
35. Bartoli C, Baeza N, Figarella C, et al. Expression of peptide 23/pancreatic associated protein and reg genes in human pituitary and adenomas. Comparison with other fetal and adult human tissues. J Clin Endocrinol Metab 1998;83:4041-6.
36. Dussetti NJ, Mallo GV, Ortiz EM, et al. Induction of lithostathine/reg mRNA expression by serum from rats with acute pancreatitis and cytokines in pancreatic acinar AR-42J cells. Arch Biochem Biophys 1996;330:129-32.
37. Krueger LJ, Lerner A, Katz SM, et al. Cystic fibrosis and diabetes mellitus: interactive or idiopathic? J Pediatr Gastroentrol Nutr 1991;13:209-19.
38. Iannucci A, Mukai K, Johnson D, et al. Endocrine pancreas in cystic fibrosis: an immunohistochemical study. Hum Pathol 1969;15:278-84.
39. Löhr M, Goertchen P, Nizze H, et al. Cystic fibrosis associated islet changes may provide a basis for diabetes. An immunocytochemical and morphometrical study. Virch Arch A Pathol Anat 1989;414:179-85.
40. Craig BG, Johnston CF, Kerr JI, et al. Evidence for pancreatic endocrine cell neoformation in cystic fibrosis. Can J Physiol Pharmacol 1986;(suppl):399.
41. Watanabe T, Yonemura Y, Yonekura H, et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci USA 1994;91:3589-92.
42. Baeza NJ, Moriscot CI, Renaud WP, et al. Pancreatic regenerating overexpression in the nonobese diabetic mouse during active diabetogenesis. Diabetes 1996;45:65-70.
43. Baeza N, Moriscot C, Figarella C, et al. Reg protein: a potential beta-cell specific growth factor? Diabete Metab 1996;22:229-34.